Cargando…
SARS-CoV-2 T-cell response in COVID-19 convalescent patients with and without lung sequelae
A specific T-cell response persists in the majority of COVID-19 patients 6 months after hospital discharge. This response is more prominent in those who required critical care during the acute COVID-19 episode but is reduced in patients with lung sequelae. https://bit.ly/3fBuVA4
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
European Respiratory Society
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8845009/ https://www.ncbi.nlm.nih.gov/pubmed/35261913 http://dx.doi.org/10.1183/23120541.00706-2021 |
| _version_ | 1784651587742859264 |
|---|---|
| author | Cruz, Tamara Mendoza, Núria Perea, Lídia Albacar, Núria Gonzalez, Azucena Hernandez-Gonzalez, Fernanda Juan, Manel Agustí, Alvar Sellares, Jacobo Sibila, Oriol Faner, Rosa |
| author_facet | Cruz, Tamara Mendoza, Núria Perea, Lídia Albacar, Núria Gonzalez, Azucena Hernandez-Gonzalez, Fernanda Juan, Manel Agustí, Alvar Sellares, Jacobo Sibila, Oriol Faner, Rosa |
| author_sort | Cruz, Tamara |
| collection | PubMed |
| description | A specific T-cell response persists in the majority of COVID-19 patients 6 months after hospital discharge. This response is more prominent in those who required critical care during the acute COVID-19 episode but is reduced in patients with lung sequelae. https://bit.ly/3fBuVA4 |
| format | Online Article Text |
| id | pubmed-8845009 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | European Respiratory Society |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-88450092022-02-16 SARS-CoV-2 T-cell response in COVID-19 convalescent patients with and without lung sequelae Cruz, Tamara Mendoza, Núria Perea, Lídia Albacar, Núria Gonzalez, Azucena Hernandez-Gonzalez, Fernanda Juan, Manel Agustí, Alvar Sellares, Jacobo Sibila, Oriol Faner, Rosa ERJ Open Res Research Letters A specific T-cell response persists in the majority of COVID-19 patients 6 months after hospital discharge. This response is more prominent in those who required critical care during the acute COVID-19 episode but is reduced in patients with lung sequelae. https://bit.ly/3fBuVA4 European Respiratory Society 2022-03-07 /pmc/articles/PMC8845009/ /pubmed/35261913 http://dx.doi.org/10.1183/23120541.00706-2021 Text en Copyright ©The authors 2022 https://creativecommons.org/licenses/by-nc/4.0/This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions@ersnet.org (mailto:permissions@ersnet.org) |
| spellingShingle | Research Letters Cruz, Tamara Mendoza, Núria Perea, Lídia Albacar, Núria Gonzalez, Azucena Hernandez-Gonzalez, Fernanda Juan, Manel Agustí, Alvar Sellares, Jacobo Sibila, Oriol Faner, Rosa SARS-CoV-2 T-cell response in COVID-19 convalescent patients with and without lung sequelae |
| title | SARS-CoV-2 T-cell response in COVID-19 convalescent patients with and without lung sequelae |
| title_full | SARS-CoV-2 T-cell response in COVID-19 convalescent patients with and without lung sequelae |
| title_fullStr | SARS-CoV-2 T-cell response in COVID-19 convalescent patients with and without lung sequelae |
| title_full_unstemmed | SARS-CoV-2 T-cell response in COVID-19 convalescent patients with and without lung sequelae |
| title_short | SARS-CoV-2 T-cell response in COVID-19 convalescent patients with and without lung sequelae |
| title_sort | sars-cov-2 t-cell response in covid-19 convalescent patients with and without lung sequelae |
| topic | Research Letters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8845009/ https://www.ncbi.nlm.nih.gov/pubmed/35261913 http://dx.doi.org/10.1183/23120541.00706-2021 |
| work_keys_str_mv | AT cruztamara sarscov2tcellresponseincovid19convalescentpatientswithandwithoutlungsequelae AT mendozanuria sarscov2tcellresponseincovid19convalescentpatientswithandwithoutlungsequelae AT perealidia sarscov2tcellresponseincovid19convalescentpatientswithandwithoutlungsequelae AT albacarnuria sarscov2tcellresponseincovid19convalescentpatientswithandwithoutlungsequelae AT gonzalezazucena sarscov2tcellresponseincovid19convalescentpatientswithandwithoutlungsequelae AT hernandezgonzalezfernanda sarscov2tcellresponseincovid19convalescentpatientswithandwithoutlungsequelae AT juanmanel sarscov2tcellresponseincovid19convalescentpatientswithandwithoutlungsequelae AT agustialvar sarscov2tcellresponseincovid19convalescentpatientswithandwithoutlungsequelae AT sellaresjacobo sarscov2tcellresponseincovid19convalescentpatientswithandwithoutlungsequelae AT sibilaoriol sarscov2tcellresponseincovid19convalescentpatientswithandwithoutlungsequelae AT fanerrosa sarscov2tcellresponseincovid19convalescentpatientswithandwithoutlungsequelae |